Nurmemmedov E - Search Results

1

Thrombospondin-1 counteracts the p97 inhibitor CB-5083 in colon carcinoma cells.

Her NG, Kesari S, Nurmemmedov E. Her NG, et al. Among authors: nurmemmedov e. Cell Cycle. 2020 Jul;19(13):1590-1601. doi: 10.1080/15384101.2020.1754584. Epub 2020 May 19. Cell Cycle. 2020. PMID: 32423265 Free PMC article.

2

Allosteric inhibitor of β-catenin selectively targets oncogenic Wnt signaling in colon cancer.

Cheltsov A, Nomura N, Yenugonda VM, Roper J, Mukthavaram R, Jiang P, Her NG, Babic I, Kesari S, Nurmemmedov E. Cheltsov A, et al. Among authors: nurmemmedov e. Sci Rep. 2020 May 15;10(1):8096. doi: 10.1038/s41598-020-60784-y. Sci Rep. 2020. PMID: 32415084 Free PMC article.

3

A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in glioma.

Yenugonda V, Nomura N, Kouznetsova V, Tsigelny I, Fogal V, Nurmemmedov E, Kesari S, Babic I. Yenugonda V, et al. Among authors: nurmemmedov e. J Transl Med. 2017 Oct 18;15(1):210. doi: 10.1186/s12967-017-1312-7. J Transl Med. 2017. PMID: 29047383 Free PMC article.

4

Cellular thermal shift analysis for interrogation of CRISPR-assisted proteomic changes.

Her NG, Babic I, Yenugonda VM, Kesari S, Nurmemmedov E. Her NG, et al. Among authors: nurmemmedov e. Biotechniques. 2020 Apr;68(4):180-184. doi: 10.2144/btn-2019-0100. Epub 2020 Feb 10. Biotechniques. 2020. PMID: 32040335 Free article.

5

Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis.

Kim MS, Gernapudi R, Cedeño YC, Polster BM, Martinez R, Shapiro P, Kesari S, Nurmemmedov E, Passaniti A. Kim MS, et al. Among authors: nurmemmedov e. Oncotarget. 2020 Oct 27;11(43):3863-3885. doi: 10.18632/oncotarget.27743. eCollection 2020 Oct 27. Oncotarget. 2020. PMID: 33196708 Free PMC article.

6

Small molecules inhibitors of the heterogeneous ribonuclear protein A18 (hnRNP A18): a regulator of protein translation and an immune checkpoint.

Solano-Gonzalez E, Coburn KM, Yu W, Wilson GM, Nurmemmedov E, Kesari S, Chang ET, MacKerell AD, Weber DJ, Carrier F. Solano-Gonzalez E, et al. Among authors: nurmemmedov e. Nucleic Acids Res. 2021 Feb 22;49(3):1235-1246. doi: 10.1093/nar/gkaa1254. Nucleic Acids Res. 2021. PMID: 33398344 Free PMC article.

7

WNT Signaling as a Therapeutic Target for Glioblastoma.

Latour M, Her NG, Kesari S, Nurmemmedov E. Latour M, et al. Among authors: nurmemmedov e. Int J Mol Sci. 2021 Aug 5;22(16):8428. doi: 10.3390/ijms22168428. Int J Mol Sci. 2021. PMID: 34445128 Free PMC article. Review.

8

Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastoma.

Tsigelny IF, Mukthavaram R, Kouznetsova VL, Chao Y, Babic I, Nurmemmedov E, Pastorino S, Jiang P, Calligaris D, Agar N, Scadeng M, Pingle SC, Wrasidlo W, Makale MT, Kesari S. Tsigelny IF, et al. Among authors: nurmemmedov e. Oncotarget. 2017 Apr 4;8(14):22370-22384. doi: 10.18632/oncotarget.5633. Oncotarget. 2017. PMID: 26517684 Free PMC article.

9

Pritumumab, the first therapeutic antibody for glioma patients.

Babic I, Nurmemmedov E, Yenugonda VM, Juarez T, Nomura N, Pingle SC, Glassy MC, Kesari S. Babic I, et al. Among authors: nurmemmedov e. Hum Antibodies. 2018 Feb 5;26(2):95-101. doi: 10.3233/HAB-170326. Hum Antibodies. 2018. PMID: 29036806 Review.

10

Wnt pathway: a hallmark of drug discovery challenge.

Babic I, Yenugonda VM, Kesari S, Nurmemmedov E. Babic I, et al. Among authors: nurmemmedov e. Future Med Chem. 2018 Jun 1;10(12):1399-1403. doi: 10.4155/fmc-2018-0084. Epub 2018 May 21. Future Med Chem. 2018. PMID: 29779411 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page